Research comparing clinical outcomes between patients receiving nafcillin and cefazolin for treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia shows that overall treatment ...

Beta-lactams are superior to vancomycin for definitive therapy, but not empiric treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infection, according to a large ...

Linezolid Nosocomial pneumonia, cSSSI Oral and intravenous form available, bacteriostatic, not approved for catheter-related bloodstream infections, side effects include myelosuppression, ...

Cefazolin offers reduced mortality and similar recurrence rates vs. the penicillinase-stable penicillins (PSPs) nafcillin or oxacillin in patients with methicillin-susceptible Staphylococcus aureus ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

Cefazolin is a first‐generation cephalosporin widely used in the treatment of infections caused by methicillin-susceptible Staphylococcus aureus (MSSA). Its favourable safety profile and reduced risk ...

Clearance for these sample types will double the accessible market for KeyPath™ to more than 90% of U.S. hospitals. On May 6, 2011, MicroPhage received initial 510(k) clearance from the U.S. Food and ...

Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today that data ...